Issue 33, 2014

Folic acid-conjugated hollow mesoporous silica/CuS nanocomposites as a difunctional nanoplatform for targeted chemo-photothermal therapy of cancer cells

Abstract

In this work, we have developed a novel difunctional nanoplatform for targeted chemo-photothermal therapy. It is based on hollow mesoporous silica nanospheres as a carrier for anticancer drug-loading CuS nanoparticles attached on a silica nanosphere surface as a photothermal agent, and folic acid (FA) conjugated with a silica nanosphere as a cancer cell target. The nanoplatform has demonstrated a good photothermal effect and excellent doxorubicin (DOX) loading capacity (as high as 49.3 wt%). The photothermal agent and DOX can be targeted to deliver into cancer cells via a receptor mediated endocytosis pathway. Moreover, the release of DOX from the hollow mesoporous silica nanospheres can be triggered by pH and NIR light. Both chemotherapy and photothermal therapy can be simultaneously driven by irradiation with a 980 nm laser. More importantly, the combination of chemotherapy and photothermal therapy shows a better therapy effect than the individual therapies, thus demonstrating a synergistic action.

Graphical abstract: Folic acid-conjugated hollow mesoporous silica/CuS nanocomposites as a difunctional nanoplatform for targeted chemo-photothermal therapy of cancer cells

Supplementary files

Article information

Article type
Paper
Submitted
06 Jun 2014
Accepted
20 Jun 2014
First published
24 Jun 2014

J. Mater. Chem. B, 2014,2, 5358-5367

Folic acid-conjugated hollow mesoporous silica/CuS nanocomposites as a difunctional nanoplatform for targeted chemo-photothermal therapy of cancer cells

X. Liu, F. Fu, K. Xu, R. Zou, J. Yang, Q. Wang, Q. Liu, Z. Xiao and J. Hu, J. Mater. Chem. B, 2014, 2, 5358 DOI: 10.1039/C4TB00919C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements